Understanding HIV prevention preferences among Liberian adolescent girls and young women
Official title: HIV PrEP Perspectives of Liberian Adolescent Girls and Young Women and their Providers
Funded at Univ of North Carolina Chapel Hill · NIH-10788449 · Data updated 2026-11-12
This study is talking to young women and girls in Liberia to learn what they think about using a medicine called PrEP that helps prevent HIV, so we can better understand what encourages them to use it and what challenges they face in getting it.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project start | February 15, 2023 |
| Project end | January 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $139,701 |
| NIH project number | 5R21MH130265-02 |
| Project ID | NIH-10788449 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adolescent girls and young women in Liberia who are at risk of HIV infection.
✕Less likely to help
Patients who are not at risk of HIV or those outside the age range of adolescent girls and young women may not benefit from this research.
What this research studies
This research investigates the perspectives of adolescent girls and young women in Liberia regarding Pre-Exposure Prophylaxis (PrEP), a preventive treatment for HIV. It aims to understand the factors influencing their willingness to use PrEP and the barriers they face in accessing it. By engaging with both the young women and their healthcare providers, the study seeks to gather insights that can inform the development of tailored PrEP programs that meet the specific needs of this population. The research will involve qualitative interviews and surveys to capture a comprehensive view of attitudes and decision-making processes related to HIV prevention.
Why it matters
Potential benefit: If successful, this research could lead to more effective and accessible HIV prevention strategies for adolescent girls and young women in Liberia.
How similar studies have gone: Other research has shown success in understanding PrEP uptake in different populations, but this specific focus on Liberian adolescent girls and young women is relatively novel.
Where this research is happening
-
Univ of North Carolina Chapel Hill
Chapel Hill, United States Active
Researchers
- Principal investigator: Wohl, David a — Univ of North Carolina Chapel Hill
- Study coordinator: Wohl, David a
Related research
Other NIH-funded projects on the same topics.
-
mChoice: Boosting PrEP Use and Adherence for Black and Latino MSM with Tailored Training and Support
A national study to help Black and Latino men who have sex with men start and stick with PrEP through culturally matched provider training and patient support.
-
Harnessing male peer networks to boost HIV testing and PrEP use
A large clinical trial in South Africa tests whether giving HIV self-test kits through male peer networks, with phone support, increases PrEP uptake among men.
-
Harnessing men's peer networks to boost HIV self-testing and PrEP use
A large project in South Africa tests whether giving HIV self-test kits through men’s social networks, with phone support, can lead to more men starting PrEP and using HIV testing.
-
Participatory system dynamics to improve PrEP access in the Bronx
A community-driven project in the Bronx will use system dynamics to identify practical ways to help people at risk for HIV start and stay on PrEP.
-
TB PrEP: Bringing HIV prevention to households affected by TB in Uganda
Aims to help people in households with TB in Uganda access HIV PrEP as part of a combined prevention approach.
-
CARES: A practical program to help adolescent girls and young women use PrEP in Africa
A program called CARES helps young women in South Africa and Zimbabwe use different PrEP options better, with counseling, reminders, and options for support.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.